Hello! If you look for a medication modeling workforce: At the moment we do see a big amount of work happening in the ISO world, and also involving CEN and WHO, with EMEA and others:
Here is a list of some of the work items: Individual Case Safety Report (ICSR) DIS (erwartet f?r Februar 2009): * Part 1. ICSR Framework Reference Model (prEN ISO 27953-1) * Part 2. ICSR Human pharmaceuticals (prEN ISO 27953-2), will be used by the "International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH)" - Identification of Medicinal Products (IDMP) CD (announced for mid January 2009): * prEN ISO 11615: Data Elements and Structures for the Exchange of Regulated Medicinal Product Information for Drug Dictionaries (MPID) * prEN ISO 11616: Structures and Controlled Vocabularies for Pharmaceutical Product Identifiers (PhPIDs) * prEN ISO 11238: Structures and Controlled Vocabularies for Ingredients (substances) * prEN ISO 11239: Structures and Controlled Vocabularies for Pharmaceutical Dose Forms, Units of Presentation and Routes of Administration * prEN ISO 11240: Structures and Controlled Vocabularies for Units of Measurement * prEN ISO 11595: Structures and Controlled Vocabularies for Laboratory Test Units for the Reporting of Laboratory Results Has somebody looked at those / are we connected to this ? I will also relay this list to the IEEE 11073 Personal Healthcare Devices (PHD) group, they are at the moment working on a medication dispensing device, and have the same problem of "techies needing some clinical input". Greetings from Vienna, Stefan Sauermann > -----Urspr?ngliche Nachricht----- > Von: openehr-clinical-bounces at openehr.org > [mailto:openehr-clinical-bounces at openehr.org] Im Auftrag von > Grahame Grieve > Gesendet: Mittwoch, 21. J?nner 2009 02:15 > An: For openEHR clinical discussions > Betreff: Re: a model for medication strengths > > > Diego: > > > > I agree that UCUM might be a useful within a model - > however, I just > > don't think a single PQ covers the scope of strengths that > I am seeing > > in use in Australian medications (they become a lot more complex). ... > > One of the big problems is that the discussion is dominated > by our collective weaknesses, and we do not know how to ask > what the proper way to do things is. > > Grahame
